Financial reports
ARS
2023 FY
Annual report to shareholders
18 Apr 24
10-K
2023 FY
Annual report
18 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
13 Apr 23
10-K
2022 FY
Annual report
2 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
18 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Jan 24
8-K
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
8 Jan 24
8-K
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
14 Nov 23
8-K
Entry into a Material Definitive Agreement
14 Sep 23
8-K
Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results
9 Aug 23
8-K
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
8 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
8-K
Singular Genomics Reports Recent Highlights and First Quarter 2023 Financial Results
9 May 23
Registration and prospectus
S-8
Registration of securities for employees
18 Mar 24
S-8
Registration of securities for employees
2 Mar 23
SC TO-I/A
Issuer tender offer statement (amended)
22 Aug 22
424B5
Prospectus supplement for primary offering
9 Aug 22
SC TO-I
Issuer tender offer statement
25 Jul 22
S-3
Shelf registration
19 Jul 22
S-8
Registration of securities for employees
14 Mar 22
S-8
Registration of securities for employees
25 Aug 21
424B4
Prospectus supplement with pricing info
28 May 21
S-8
Registration of securities for employees
27 May 21
Proxies
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
PRE 14A
Preliminary proxy
5 Apr 24
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
DEFA14A
Additional proxy soliciting materials
25 Jul 22
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
Other
EFFECT
Notice of effectiveness
28 Jul 22
CORRESP
Correspondence with SEC
25 Jul 22
UPLOAD
Letter from SEC
25 Jul 22
EFFECT
Notice of effectiveness
27 May 21
CERT
Certification of approval for exchange listing
27 May 21
SEC STAFF
SEC staff action: Order
27 May 21
CORRESP
Correspondence with SEC
24 May 21
CORRESP
Correspondence with SEC
24 May 21
CORRESP
Correspondence with SEC
12 May 21
SEC STAFF
SEC staff action: Order
11 May 21